Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Digestive Disorder

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1410558

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1410558

Gastrointestinal Infection Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

PUBLISHED:
PAGES: 213 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PPT Slides/PDF & Excel (Enterprise License)
USD 4995

Add to Cart

Description

Table of Contents

Gastrointestinal infections are among the most prevalent health concerns in primary care, leading to a rising demand for gastrointestinal infection testing. These tests are crucial for detecting bacteria, viruses, and parasites responsible for such infections. The global gastrointestinal infection testing market is expected to witness substantial growth during forecast period. By 2031, the market is estimated to reach a value of $US 600 million.

Key Drivers of the Gastrointestinal Infection Testing Market

  • Increasing Prevalence of Gastrointestinal Infections: The market is experiencing rapid expansion due to a growing number of individuals suffering from gastrointestinal infections caused by viruses, parasites, and bacteria. Poor dietary habits and digestive-related ailments contribute to the rising prevalence of gastrointestinal infections, driving demand for improved testing solutions. The market's growth is closely linked to the increasing patient population affected by gastrointestinal infections.
  • Technological Advancements in Testing Solutions: Technological advancements in gastrointestinal infection testing equipment are poised to boost the market further. These innovations have led to the development of new testing solutions capable of swiftly identifying infectious pathogens, such as bacteria, viruses, and parasites. The demand for precise and rapid pathogen detection is driving researchers and manufacturers to create new testing solutions, contributing to market growth.

Restraints to the Gastrointestinal Infection Testing Market

Despite the market's potential for growth, challenges such as improper regulatory guidelines and limited awareness of advanced molecular diagnostic techniques may hinder its expansion. Inadequate sanitation facilities, insufficient medical infrastructure, and unsanitary practices, particularly in emerging economies, could impede market growth.

Competitive Landscape

The global Gastrointestinal Infection Testing Market is moderately competitive, with a mix of domestic and international players, dominated by global industry leaders. Emerging players in the market are actively pursuing both organic and inorganic strategies to expand their product footprint in the global gastrointestinal infection testing market.

Key Companies Profiled

  • Becton, Dickinson and Company (BD)
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Luminex Corporation
  • Hoffmann-La Roche Ltd.
  • bioMerieux SA
  • Quidel Corporation
  • Illumina, Inc.
  • Seegene Inc.
  • Genetic Signatures

Gastrointestinal Infection Testing Market Categorization

Gastrointestinal Infection Testing Market by End User

  • Hospitals
  • Clinics/Medical Centers
  • Diagnostic Laboratories
  • Research Institutes

Gastrointestinal Infection Testing Market by Disease Strains

  • Bacterial Strains
  • Viral Strains
  • Parasitic Strains

Gastrointestinal Infection Testing Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Gastrointestinal Infection Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Gastrointestinal Infection Testing Market Outlook, 2018 - 2031

  • 3.1. Global Gastrointestinal Infection Testing Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Hospitals
      • 3.1.1.2. Clinics/Medical Centers
      • 3.1.1.3. Diagnostic Laboratories
      • 3.1.1.4. Research Institutes
  • 3.2. Global Gastrointestinal Infection Testing Market Outlook, by Disease Strains, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Bacterial Strains
      • 3.2.1.2. Viral Strains
      • 3.2.1.3. Parasitic Strains
  • 3.3. Global Gastrointestinal Infection Testing Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Gastrointestinal Infection Testing Market Outlook, 2018 - 2031

  • 4.1. North America Gastrointestinal Infection Testing Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Hospitals
      • 4.1.1.2. Clinics/Medical Centers
      • 4.1.1.3. Diagnostic Laboratories
      • 4.1.1.4. Research Institutes
  • 4.2. North America Gastrointestinal Infection Testing Market Outlook, by Disease Strains, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Bacterial Strains
      • 4.2.1.2. Viral Strains
      • 4.2.1.3. Parasitic Strains
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Gastrointestinal Infection Testing Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 4.3.1.2. U.S. Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 4.3.1.3. Canada Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 4.3.1.4. Canada Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Gastrointestinal Infection Testing Market Outlook, 2018 - 2031

  • 5.1. Europe Gastrointestinal Infection Testing Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Hospitals
      • 5.1.1.2. Clinics/Medical Centers
      • 5.1.1.3. Diagnostic Laboratories
      • 5.1.1.4. Research Institutes
  • 5.2. Europe Gastrointestinal Infection Testing Market Outlook, by Disease Strains, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Bacterial Strains
      • 5.2.1.2. Viral Strains
      • 5.2.1.3. Parasitic Strains
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Gastrointestinal Infection Testing Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.2. Germany Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 5.3.1.3. U.K. Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.4. U.K. Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 5.3.1.5. France Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.6. France Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 5.3.1.7. Italy Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.8. Italy Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 5.3.1.9. Turkey Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.10. Turkey Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 5.3.1.11. Russia Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.12. Russia Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Gastrointestinal Infection Testing Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Gastrointestinal Infection Testing Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Hospitals
      • 6.1.1.2. Clinics/Medical Centers
      • 6.1.1.3. Diagnostic Laboratories
      • 6.1.1.4. Research Institutes
  • 6.2. Asia Pacific Gastrointestinal Infection Testing Market Outlook, by Disease Strains, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Bacterial Strains
      • 6.2.1.2. Viral Strains
      • 6.2.1.3. Parasitic Strains
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Gastrointestinal Infection Testing Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.2. China Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 6.3.1.3. Japan Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.4. Japan Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 6.3.1.5. South Korea Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.6. South Korea Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 6.3.1.7. India Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.8. India Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Gastrointestinal Infection Testing Market Outlook, 2018 - 2031

  • 7.1. Latin America Gastrointestinal Infection Testing Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Hospitals
      • 7.1.1.2. Clinics/Medical Centers
      • 7.1.1.3. Diagnostic Laboratories
      • 7.1.1.4. Research Institutes
  • 7.2. Latin America Gastrointestinal Infection Testing Market Outlook, by Disease Strains, Value (US$ Mn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Bacterial Strains
      • 7.2.1.2. Viral Strains
      • 7.2.1.3. Parasitic Strains
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Gastrointestinal Infection Testing Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.2. Brazil Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 7.3.1.3. Mexico Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.4. Mexico Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 7.3.1.5. Argentina Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.6. Argentina Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Gastrointestinal Infection Testing Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Gastrointestinal Infection Testing Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Hospitals
      • 8.1.1.2. Clinics/Medical Centers
      • 8.1.1.3. Diagnostic Laboratories
      • 8.1.1.4. Research Institutes
  • 8.2. Middle East & Africa Gastrointestinal Infection Testing Market Outlook, by Disease Strains, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Bacterial Strains
      • 8.2.1.2. Viral Strains
      • 8.2.1.3. Parasitic Strains
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Gastrointestinal Infection Testing Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.2. GCC Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 8.3.1.3. South Africa Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.4. South Africa Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 8.3.1.5. Egypt Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.6. Egypt Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 8.3.1.7. Nigeria Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.8. Nigeria Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Gastrointestinal Infection Testing Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Gastrointestinal Infection Testing Market by Disease Strains, Value (US$ Mn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By End User vs by Disease Strains Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Becton, Dickinson and Company (BD)
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Therapy Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Thermo Fisher Scientific Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Therapy Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Bio-Rad Laboratories Inc.
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Therapy Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Luminex Corporation
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Therapy Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Hoffmann-La Roche Ltd.
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Therapy Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. bioMerieux SA
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Therapy Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Quidel Corporation
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Therapy Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Illumina, Inc.
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Therapy Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Seegene Inc
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Therapy Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Genetic Signatures
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Therapy Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!